cris.boxmetadata.label.title
Normalization of FoxP3+ regulatory T cells in response to effective antiretroviral therapy
cris.boxmetadata.label.dateissued
15 browse.startsWith.months.february 2011
cris.boxmetadata.label.accesslevel
open access
cris.boxmetadata.label.resourcetype
journal article
cris.boxmetadata.label.authors
MONTES DELGADO, MARTIN
SANCHEZ NEIRA, CESAR AUGUSTO
Lewis D.E.
Graviss E.A.
SEAS RAMOS, CARLOS RAFAEL
GOTUZZO HERENCIA, JOSE EDUARDO
cris.boxmetadata.label.abstract
Regulatory T cells (Tregs) blunt uncontrolled immune responses. In advanced human immunodeficiency virus (HIV) infection, the total number of Tregs is decreased, but the proportion of T cells with a regulatory phenotype is highly variable. We studied CD4+CD25+FoxP3+ T cells from patients successfully treated with combination antiretroviral therapy (ART). The proportion of CD4+CD25+FoxP3+ cells transiently increased and then decreased from a median of 13% at baseline to 5.1% at 48 weeks, similar to values in normal subjects. These data suggest that with effective therapy, the regulatory cell numbers normalize, and that the inflammatory signals driving their production may also abate. © The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
cris.boxmetadata.label.citationstartpage
496
cris.boxmetadata.label.citationendpage
499
cris.boxmetadata.label.volume
203
cris.boxmetadata.label.issue
4
cris.boxmetadata.label.language
English
cris.boxmetadata.label.ocdeknowledgeArea
Medicina tropical Enfermedades infecciosas
cris.boxmetadata.label.doi
cris.boxmetadata.label.scopusidentifier
2-s2.0-79751470192
cris.boxmetadata.label.pubmedidentifier
cris.boxmetadata.label.source
Journal of Infectious Diseases
cris.boxmetadata.label.containerissn
00221899
cris.boxmetadata.label.sponsor
This study was supported in part by the National Institutes of Health (1R56AI078871), the Baylor-UT Houston Center for AIDS Research Core Support Grant AI36211 from the National Institute of Allergy and Infectious Diseases, and a Fogarty Center Training grant (D43TW006569).
peru-layout.shadow-copies Directorio de Producción Científica Scopus